Anti-PLB1/ PLB/ PLB/LIP monoclonal antibody
Anti-PLB1/ PLB/ PLB/LIP antibody for FACS & in-vivo assay
Go to PLB1/PLB1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-MP1381-Ab-1/ GM-Tg-hg-MP1381-Ab-2 | Anti-Human PLB1 monoclonal antibody | Human |
GM-Tg-rg-MP1381-Ab-1/ GM-Tg-rg-MP1381-Ab-2 | Anti-Rat PLB1 monoclonal antibody | Rat |
GM-Tg-mg-MP1381-Ab-1/ GM-Tg-mg-MP1381-Ab-2 | Anti-Mouse PLB1 monoclonal antibody | Mouse |
GM-Tg-cynog-MP1381-Ab-1/ GM-Tg-cynog-MP1381-Ab-2 | Anti-Cynomolgus/ Rhesus macaque PLB1 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-MP1381-Ab-1/ GM-Tg-felg-MP1381-Ab-2 | Anti-Feline PLB1 monoclonal antibody | Feline |
GM-Tg-cang-MP1381-Ab-1/ GM-Tg-cang-MP1381-Ab-2 | Anti-Canine PLB1 monoclonal antibody | Canine |
GM-Tg-bovg-MP1381-Ab-1/ GM-Tg-bovg-MP1381-Ab-2 | Anti-Bovine PLB1 monoclonal antibody | Bovine |
GM-Tg-equg-MP1381-Ab-1/ GM-Tg-equg-MP1381-Ab-2 | Anti-Equine PLB1 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-MP1381-Ab-1/ GM-Tg-hg-MP1381-Ab-2; GM-Tg-rg-MP1381-Ab-1/ GM-Tg-rg-MP1381-Ab-2; GM-Tg-mg-MP1381-Ab-1/ GM-Tg-mg-MP1381-Ab-2; GM-Tg-cynog-MP1381-Ab-1/ GM-Tg-cynog-MP1381-Ab-2; GM-Tg-felg-MP1381-Ab-1/ GM-Tg-felg-MP1381-Ab-2; GM-Tg-cang-MP1381-Ab-1/ GM-Tg-cang-MP1381-Ab-2; GM-Tg-bovg-MP1381-Ab-1/ GM-Tg-bovg-MP1381-Ab-2; GM-Tg-equg-MP1381-Ab-1/ GM-Tg-equg-MP1381-Ab-2 |
Products Name | Anti-PLB1 monoclonal antibody |
Format | mab |
Target Name | PLB1 |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-PLB1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species PLB1/ PLB/ PLB/LIP VLP (virus-like particle) (Products Developing) |
Target information
Target ID | GM-MP1381 |
Target Name | PLB1 |
Gene ID | 151056,665270,192259,100424557,611194,101089599,506508,100071076 |
Gene Symbol and Synonyms | 4632413E21Rik,4930433E17Rik,4930539A06Rik,Phlpb,PLB,PLB/LIP,PLB1 |
Uniprot Accession | Q6P1J6,O54728 |
Uniprot Entry Name | PLB1_HUMAN,PLB1_RAT |
Protein Sub-location | Transmembrane Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000163803 |
Target Classification | N/A |
The target: PLB1, gene name: PLB1, also named as PLB, PLB/LIP. This gene encodes a membrane-associated phospholipase that displays lysophospholipase and phospholipase A2 activities through removal of sn-1 and sn-2 fatty acids of glycerophospholipids. In addition, it displays lipase and retinyl ester hydrolase activities. The encoded protein is highly conserved and is composed of a large, glycosylated extracellular domain composed of four tandem homologous domains, followed by a hydrophobic segment that anchors the enzyme to the membrane and a short C-terminal cytoplasmic tail. This gene has been identified as a candidate rheumatoid arthritis risk gene. [provided by RefSeq, Jul 2016].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.